Universitätsklinikum Erlangen

Research results from Erlangen are setting new standards for prevention, diagnostics and therapy. With 43 departments and eight institutes that comprehend every field of modern medicine, every patient at Erlangen benefits from the latest available treatment methods.

Thanks to initiatives such as the Comprehensive Cancer Center WERA and Bavarian Cancer Research Center (BZKF; governed by Erlangen), Erlangen is considered among few centers of excellence for oncology research and treatment, fostering interdisciplinary approaches between medical care, research, and teaching. Recently Erlangen as part of CCC WERA alliance has also been appointed as part of the National Center for Tumor Diseases (NCT WERA) by the German state government, and will be a future driver of excellence in oncology and cancer research.

Erlangen is a major contributor to the MOSAIC project. Their deep expertise in cancer research – especially in tumor immunology- using both clinical data and biomaterials is a core asset for MOSAIC, enhancing disease courses analysis, fostering improved treatments development, and enabling new investigational methods at the highest scientific standards.